US FDA explains info needed for formal product classification requests
This article was originally published in SRA
Executive Summary
The US Food and Drug Administration has issued revised guidance explaining the type of information that companies should submit when seeking a formal determination of the regulatory identity of their product as a drug, device, biological or combination product1,2. The company's request for designation (RFD) results in the FDA assigning the product's pre-market review responsibility based on the product's "primary mode of action".
You may also be interested in...
More Guidance Coming On Common Combo Product Designation Mistakes
US FDA's Office of Combination Products hopes Q&A guidance will help lower high refusal rate on requests for designation.
Common Combo Product Designation Mistakes To Be Outlined In Upcoming Guidance
US FDA's Office of Combination Products hopes Q&A guidance will help lower high refusal rate on requests for designation.
Global Pharma Guidance Tracker – March 2024
Stay up to date on regulatory guidelines from around the world with the Pink Sheet's Guidance Tracker. The complete Global Pharma Guidance Tracker, with sortable and searchable listings going back to 2014, is available online.